Literature DB >> 19726513

Novel role for interleukin-2 receptor-Jak signaling in retrovirus transmission.

J M Taylor1, M Brown, M Nejmeddine, K J Kim, L Ratner, M Lairmore, C Nicot.   

Abstract

Human T-lymphotropic virus type 1 (HTLV-1) is the etiological agent of adult T-cell leukemia/lymphoma, and it encodes a number of nonstructural proteins that are involved in virus replication and immune evasion. The viral protein p12 previously has been characterized to interfere with major histocompatibility complex class, ICAM-1, and ICAM-2 expression, and it activates STAT5. Using a previously established T-cell line immortalized with an HTLV-1 molecular clone deleted for p12, we assessed the role of p12 in regulating cellular growth and virus transmission. These cells were complemented for p12 expression by the transduction of a lentivirus vector expressing p12. We report that p12 conferred a selective growth advantage in vitro and increased the colony formation of human T cells in soft-agar assays. Consistently with previous studies, p12- and p12+ cell lines produced similar amounts of virus particles released into the supernatant of cultured cells, although we found that p12 expression greatly enhanced virus transmission. Moreover, we found that interleukin-2 (IL-2) stimulation also increased HTLV-1 transmission whether p12 was expressed or not, and inversely, that the inhibition of Jak signaling significantly reduced HTLV-1 transmission. Intriguingly, IL-2/Jak signaling was not associated with changes in viral gene expression, viral RNA encapsidation, the maturation of the virus particle, cell-cell adherence, or Gag polarization and virological synapse formation. We do demonstrate, however, that IL-2 stimulation and p12 expression significantly increased the rate of syncytium formation, revealing a novel role for IL-2 signaling and Jak activation in HTLV-1 virus transmission.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19726513      PMCID: PMC2772716          DOI: 10.1128/JVI.00952-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  71 in total

1.  Inhibition of T-cell receptor signal transduction and viral expression by the linker for activation of T cells-interacting p12(I) protein of human T-cell leukemia/lymphoma virus type 1.

Authors:  Risaku Fukumoto; Miroslav Dundr; Christophe Nicot; Anthony Adams; Valerio W Valeri; Lawrence E Samelson; Genoveffa Franchini
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

2.  Functional replacement of the HIV-1 rev protein by the HTLV-1 rex protein.

Authors:  L Rimsky; J Hauber; M Dukovich; M H Malim; A Langlois; B R Cullen; W C Greene
Journal:  Nature       Date:  1988-10-20       Impact factor: 49.962

3.  HTLV-1-Tax and ICAM-1 act on T-cell signal pathways to polarize the microtubule-organizing center at the virological synapse.

Authors:  Mohamed Nejmeddine; Veera S Negi; Sohini Mukherjee; Yuetsu Tanaka; Kim Orth; Graham P Taylor; Charles R M Bangham
Journal:  Blood       Date:  2009-06-03       Impact factor: 22.113

4.  Human T-cell leukemia virus type I envelope protein maturation process: requirements for syncytium formation.

Authors:  C Pique; D Pham; T Tursz; M C Dokhélar
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

5.  Intersubunit disulfide isomerization controls membrane fusion of human T-cell leukemia virus Env.

Authors:  Kejun Li; Shujing Zhang; Malin Kronqvist; Michael Wallin; Maria Ekström; David Derse; Henrik Garoff
Journal:  J Virol       Date:  2008-05-14       Impact factor: 5.103

6.  Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells.

Authors:  Kathryn S Jones; Cari Petrow-Sadowski; Ying K Huang; Daniel C Bertolette; Francis W Ruscetti
Journal:  Nat Med       Date:  2008-03-23       Impact factor: 53.440

7.  Association of intercellular adhesion molecule 1 with the multichain high-affinity interleukin 2 receptor.

Authors:  J Burton; C K Goldman; P Rao; M Moos; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

Review 8.  Regulation of telomerase and telomeres: human tumor viruses take control.

Authors:  Marcia Bellon; Christophe Nicot
Journal:  J Natl Cancer Inst       Date:  2008-01-08       Impact factor: 13.506

9.  Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.

Authors:  Prabal Banerjee; Gerold Feuer; Edward Barker
Journal:  J Virol       Date:  2007-07-03       Impact factor: 5.103

10.  Induction of galectin-1 expression by HTLV-I Tax and its impact on HTLV-I infectivity.

Authors:  Sonia Gauthier; Isabelle Pelletier; Michel Ouellet; Amandine Vargas; Michel J Tremblay; Sachiko Sato; Benoit Barbeau
Journal:  Retrovirology       Date:  2008-11-25       Impact factor: 4.602

View more
  18 in total

1.  Human T-cell leukemia virus type 1 p8 protein increases cellular conduits and virus transmission.

Authors:  Nancy Van Prooyen; Heather Gold; Vibeke Andresen; Owen Schwartz; Kathryn Jones; Frank Ruscetti; Stephen Lockett; Prabhakar Gudla; David Venzon; Genoveffa Franchini
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-12       Impact factor: 11.205

2.  Human T-lymphotropic type 1 virus p30 inhibits homologous recombination and favors unfaithful DNA repair.

Authors:  Hicham H Baydoun; Joanna Pancewicz; Christophe Nicot
Journal:  Blood       Date:  2011-03-22       Impact factor: 22.113

Review 3.  Human T-lymphotropic virus proteins and post-translational modification pathways.

Authors:  Carlo Bidoia
Journal:  World J Virol       Date:  2012-08-12

Review 4.  Hijacking the T-cell communication network by the human T-cell leukemia/lymphoma virus type 1 (HTLV-1) p12 and p8 proteins.

Authors:  Nancy Van Prooyen; Vibeke Andresen; Heather Gold; Izabela Bialuk; Cynthia Pise-Masison; Genoveffa Franchini
Journal:  Mol Aspects Med       Date:  2010-07-29

Review 5.  Cell cycle regulation during viral infection.

Authors:  Sumedha Bagga; Michael J Bouchard
Journal:  Methods Mol Biol       Date:  2014

6.  Human T-lymphotropic virus type 1 p30 interacts with REGgamma and modulates ATM (ataxia telangiectasia mutated) to promote cell survival.

Authors:  Rajaneesh Anupam; Antara Datta; Matthew Kesic; Kari Green-Church; Nikolozi Shkriabai; Mamuka Kvaratskhelia; Michael D Lairmore
Journal:  J Biol Chem       Date:  2011-01-07       Impact factor: 5.157

7.  Palmitoylation and p8-mediated human T-cell leukemia virus type 1 transmission.

Authors:  Dustin Edwards; Risaku Fukumoto; Maria Fernanda de Castro-Amarante; Luiz Carlos Junior Alcantara; Bernardo Galvão-Castro; Robyn Washington Parks; Cynthia Pise-Masison; Genoveffa Franchini
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

8.  HTLV-1 subgroups associated with the risk of HAM/TSP are related to viral and host gene expression in peripheral blood mononuclear cells, independent of the transactivation functions of the viral factors.

Authors:  Keiko Yasuma; Toshio Matsuzaki; Yoshihisa Yamano; Hiroshi Takashima; Masao Matsuoka; Mineki Saito
Journal:  J Neurovirol       Date:  2015-12-03       Impact factor: 2.643

9.  Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis.

Authors:  Priya Kannian; Patrick L Green
Journal:  Viruses       Date:  2010-09-24       Impact factor: 5.818

10.  Overview on HTLV-1 p12, p8, p30, p13: accomplices in persistent infection and viral pathogenesis.

Authors:  Xue Tao Bai; Christophe Nicot
Journal:  Front Microbiol       Date:  2012-12-11       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.